Wednesday, 27 January 2021, 7:53 am
26 January 2021 – Important advances in HIV prevention
research were announced today at the 4th
HIV Research for Prevention Conference (HIVR4P //
Virtual), convened by IAS – the International AIDS
Society.
Highlights included findings from a pair of
trials evaluating whether infusions with a broadly
neutralizing antibody (bNAb) can prevent HIV acquisition and
positive interim results from a study of long-acting
injectable pre-exposure prophylaxis (PrEP) in women. Other
announcements included promising data from a study of
islatravir as a once-monthly PrEP pill, a study warning that
many African countries are not on track to meet key UNAIDS
prevention targets, new data on global uptake of PrEP, and a
Courtesy of Terri and Tom Bone
Terri and Tom Bone, donors to the Magee-Womens Research Institute for prematurity research.
TribLIVE s Daily and Weekly email newsletters deliver the news you want and information you need, right to your inbox.
Terri Bone remembered calling the neonatal intensive care unit from her hospital room to check on her newborn daughter.
“The nurse told me, ‘she stopped breathing last night, but she is OK,’ ” said Bone. “ ‘Premature babies do that sometimes.’ ”
After 10 days in the NICU at what is now UPMC Magee-Womens Hospital, baby Megan went home.
Now, 29, Megan is a pediatric neurologist in Texas. As a University of Pittsburgh medical student, she spent time in 2017 in that very same NICU where she was born five weeks early at 6 pounds.